Market Research Logo

Global Radiofrequency Ablation Market 2017-2021

Global Radiofrequency Ablation Market 2017-2021

About Radiofrequency Ablation

Radiofrequency ablation devices are used to treat medical conditions such as cancer tumors with the help of imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound by using minimally invasive (MI) techniques. This involves the use of high-frequency electromagnetic waves to generate heat energy (alternating current). Radiofrequency ablation is used by surgeons to destroy cancerous cells, and remove or trim obstructive tissues and dead nerves. The process is carried out by inserting a special needle through the skin onto the tumor. The procedure targets specific tissue/nerve with radiofrequency electrical energy, heating the tumor through an active exposed electrode tip.

Technavio’s analysts forecast the global radiofrequency ablation market to grow at a CAGR of 8.78% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global radiofrequency ablation market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of equipment and accessories used in radiofrequency ablation.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Radiofrequency Ablation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AngioDynamics
  • Boston Scientific
  • Medtronic
  • St. Jude Medical
  • Stryker
Other prominent vendors
  • Accuray
  • Advanced Cardiac Therapeutics
  • APT Medical
  • Arthrex
  • AtriCure
  • Biosense Webster
  • BIOTRONIK
  • Bovie Medical
  • CardioFocus
  • CONMED
  • DVx
  • Hansen Medical
  • Halyard Health
  • Imricor Medical Systems
  • Japan Lifeline
  • Merit Medical Systems
  • MicroPort Scientific
  • Osypka Medical
  • PLC Medical Systems
  • RF Medical
  • Smith & Nephew
  • Spacelabs Healthcare
  • Spectranetics
  • Theraclion
  • Total Vein Systems
Market driver
  • Increasing incidence of chronic disorders and growing older population
  • For a full, detailed list, view our report
Market challenge
  • Risks and complications associated with radiofrequency ablation
  • For a full, detailed list, view our report
Market trend
  • New product launches coupled with R&D activities
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Radiofrequency Ablation Market 2017-2021

Technavio recognizes the following companies as the key players in the global radiofrequency ablation market: AngioDynamics, Boston Scientific, Medtronic, St. Jude Medical, and Stryker.

Other Prominent Vendors in the market are: Accuray, Advanced Cardiac Therapeutics, APT Medical, Arthrex, AtriCure, Biosense Webster, BIOTRONIK, Bovie Medical, CardioFocus, CONMED, DVx, Hansen Medical, Halyard Health, Imricor Medical Systems, Japan Lifeline, Merit Medical Systems, MicroPort Scientific, Osypka Medical, PLC Medical Systems, RF Medical, Smith & Nephew, Spacelabs Healthcare, Spectranetics, Theraclion, and Total Vein Systems.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is new product launches coupled with R&D activities. Vendors are increasingly focusing on the development and launch of new radiofrequency ablation devices. Product launches and R&D activities will help vendors survive in the market and enhance their growth. Vendors such as Medtronic, Boston Scientific, AngioDynamics, and Merit Medical Systems are actively involved in the development of innovative devices for improving the efficacy of radiofrequency ablation procedures.”

According to the report, one of the major drivers for this market is increasing incidence of chronic disorders and growing older population. A sedentary lifestyle can negatively affect the homeostasis of the body. The dietary habits of people worldwide are changing, which make them susceptible to many disorders such as cardiovascular diseases, respiratory diseases, obesity, cancer, urology disorders, joint pain, Alzheimer's disease, and other chronic illnesses. According to the CDC data, the number of people with chronic disorders has been increasing steadily over the past two decades. So, the emphasis and focus on treatments for these diseases such as radiofrequency ablation have increased. Radiofrequency ablation devices are increasingly used to treat chest pain, joint pain, gynecological conditions, and liver and kidney problems.

Further, the report states that one of the major factors hindering the growth of this market is risks and complications associated with radiofrequency ablation. Although radiofrequency ablation is a proven MI procedure with high efficacy, certain risks and complications are associated with the procedure, which will hinder the growth prospects and will restrict their adoption among end-users. The use of energy-based ablation devices involves risks and complications not only to patients but also to physicians and operators. These devices emit hazardous radiation that can have serious, even fatal, side-effects. High-power energy devices can damage the sensitive part of the eye and the skin.

Companies Mentioned

AngioDynamics, Boston Scientific, Medtronic, St. Jude Medical, Stryker, Accuray, Advanced Cardiac Therapeutics, APT Medical, Arthrex, AtriCure, Biosense Webster, BIOTRONIK, Bovie Medical, CardioFocus, CONMED, DVx, Hansen Medical, Halyard Health, Imricor Medical Systems, Japan Lifeline, Merit Medical Systems, MicroPort Scientific, Osypka Medical, PLC Medical Systems, RF Medical, Smith & Nephew, Spacelabs Healthcare, Spectranetics, Theraclion, and Total Vein Systems.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Key market highlights
  • Market landscape
    • Market overview
      • Table Global radiofrequency ablation market 2016-2021 ($ millions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by product
    • Table Global radiofrequency ablation market by product type 2016-2021 ($ millions)
    • Table Global radiofrequency ablation market by product type 2016-2021
    • Global radiofrequency ablation consumables and accessories market
      • Table Global radiofrequency ablation consumables and accessories market 2016-2021 ($ millions)
    • Global radiofrequency ablation systems market
      • Table Global radiofrequency ablation systems market 2016-2021 ($ millions)
    • Global radiofrequency ablation catheters market
      • Table Common ablation catheters used during radiofrequency ablation procedure
      • Table Benefits of advanced radiofrequency ablation catheters
      • Table Global radiofrequency ablation catheters market 2016-2021 ($ millions)
  • Market segmentation by application
    • Table Global radiofrequency ablation market by application 2016
    • Oncology
    • Cardiovascular
    • Pain management
    • Cosmetology
    • Gynecology
  • Market segmentation by end-user
    • Table Global radiofrequency ablation market by end-user 2016
    • Hospitals
    • ASCs
    • Physicians' offices
  • Geographical segmentation
    • Table Global radiofrequency ablation market by geography 2016-2021
    • Table Global radiofrequency ablation market by geography 2016: Lifecycle analysis
    • Table Global radiofrequency ablation market analysis by geography 2016
    • Table Global radiofrequency ablation market by geography 2016-2021 ($ millions)
    • Table Global radiofrequency ablation market by geography 2016-2021
    • Radiofrequency ablation market in Americas
      • Table Radiofrequency ablation market in Americas 2016-2021 ($ millions)
    • Radiofrequency ablation market in EMEA
      • Table Radiofrequency ablation market in EMEA 2016-2021 ($ millions)
    • Radiofrequency ablation market in APAC
      • Table Radiofrequency ablation market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Cancer types worldwide 2012
    • Impact of drivers on key customer segments
      • Table Impact of drivers
    • Market challenges
      • Table Product recalls in radiofrequency ablation market 2015-2016
    • Impact of challenges on key customer segments
      • Table Impact of challenges
  • Market trends
    • New product launches coupled with R&D activities
      • Table New product launches 2015-2016
      • Table Ongoing clinical trials for radiofrequency ablation
    • Increasing M&A
      • Table Key M&A 2016-2017
    • Emergence of robotic navigation technologies
    • Adoption of radiofrequency ablation in emerging economies
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure of global radiofrequency ablation market
      • Table Competitive parameters in global radiofrequency ablation market
  • Key vendor analysis
    • AngioDynamics
      • Table AngioDynamics: Strength assessment
      • Table AngioDynamics: Strategy assessment
      • Table AngioDynamics: Opportunity assessment
    • Boston Scientific
      • Table Boston Scientific: Strength assessment
      • Table Boston Scientific strategy assessment
      • Table Boston Scientific: Opportunity assessment
    • Medtronic
      • Table Medtronic: Strength assessment
      • Table Medtronic; Strategy assessment
      • Table Medtronic; Opportunity assessment
    • St. Jude Medical
      • Table St. Jude Medical: Strength assessment
      • Table St. Jude Medical: Strategy assessment
      • Table St. Jude Medical: Opportunity assessment
    • Stryker
      • Table Stryker: Strength assessment
      • Table Stryker: Strategy assessment
      • Table Stryker: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report